Fig. 9From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1Correlation analysis of HMGB1 and RAGE/TNF-α/VEGF/AFP at 1 month after TACE.HMGB1 = high-mobility group protein 1; RAGE = receptor for advanced glycation endproducts; TNF-α = tumor necrosis factor-α; VEGF = vascular endothelial growth factor; AFP = alpha fetoproteinBack to article page